Published in J Child Adolesc Psychopharmacol on January 01, 2001
Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis. Psychopharmacology (Berl) (2007) 1.54
Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry (2004) 1.38
Atomoxetine: a novel treatment for child and adult ADHD. Neuropsychiatr Dis Treat (2006) 1.04
Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD. J Natl Med Assoc (2005) 0.95
Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder. Arch Dis Child (2005) 0.88
A new paradigm for developing drugs in children: atomoxetine as a model. Arch Dis Child (2005) 0.76
Non-stimulant treatment for attention deficit hyperactivity disorder. Psychiatry (Edgmont) (2005) 0.75
A randomized, open-label assessment of response to various doses of atomoxetine in korean pediatric outpatients with attention-deficit/hyperactivity disorder. Psychiatry Investig (2011) 0.75
The sequence of the human genome. Science (2001) 101.55
The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis (1992) 3.04
Validation of a telephone version of the mini-mental state examination. J Am Geriatr Soc (1992) 2.64
An athymic nude mutation in the rat. Nature (1978) 2.54
Threshold of fragmentation for ultrasonic contrast agents. J Biomed Opt (2001) 2.39
Factors involved in fatty acyl CoA desaturation by fungal microsomes. The relative roles of acyl CoA and phospholipids as substrates. Eur J Biochem (1971) 2.32
Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine. Neurology (2012) 2.13
Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA (1991) 1.75
Dimensional perspective on the recognition of depressive symptoms in primary care: The Hampshire Depression Project 3. Br J Psychiatry (2001) 1.75
Error rates in cervical cytological screening tests. Br J Cancer (1974) 1.61
Repeatability of a model for measuring multi-segment foot kinematics in children. Gait Posture (2006) 1.61
The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin. Arthritis Rheum (1993) 1.61
Intestinal parasites in metropolitan Toronto day-care centres. Can Med Assoc J (1984) 1.58
GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry (2005) 1.56
Evolution and diversity of subduction zones controlled by slab width. Nature (2007) 1.54
The life-space diary: a measure of mobility in old people at home. Int Rehabil Med (1985) 1.54
Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor. Am J Physiol (1984) 1.51
Mild senile dementia of the Alzheimer type: 2. Longitudinal assessment. Ann Neurol (1988) 1.48
Emerging advantages and drawbacks of telephone surveying in public health research in Ireland and the U.K. BMC Public Health (2006) 1.47
Neurobiological studies of sensory gating in schizophrenia. Schizophr Bull (1987) 1.44
Andersen's syndrome: a distinct periodic paralysis. Ann Neurol (1997) 1.42
The neurological features of early and 'latent' human immunodeficiency virus infection. Aust N Z J Med (1989) 1.42
P300 as a predictor of recovery from coma. Lancet (1990) 1.41
Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry. J Perinatol (2008) 1.41
Overlapping symptoms of geriatric depression and Alzheimer-type dementia. Hosp Community Psychiatry (1988) 1.39
The role of 99Tcm-HMPAO white cell imaging in suspected orthopaedic infection. Br J Radiol (1992) 1.39
The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol (1999) 1.37
Posterior lumbar interbody fusion with cages: an independent review of 71 cases. J Neurosurg (1999) 1.34
The use of computers to study rates of lipid metabolism. J Lipid Res (1969) 1.31
Apolipoprotein B is structurally and metabolically heterogeneous in the rat. Proc Natl Acad Sci U S A (1981) 1.28
Relationship of lipoprotein lipase activity to triglyceride uptake in adipose tissue. J Lipid Res (1967) 1.27
Cholecystokinin mediates feedback regulation of pancreatic enzyme secretion in rats. Am J Physiol (1986) 1.23
22q11 deletion syndrome in childhood onset schizophrenia: an update. Mol Psychiatry (2004) 1.22
An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. Clin Nephrol (2008) 1.22
A review of recent findings on substance abuse treatment for pregnant women. J Subst Abuse Treat (1999) 1.21
Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection. J Infect Dis (2001) 1.20
Behavioral complications associated with donepezil. Am J Psychiatry (1998) 1.20
The continued emergence of hantaviruses: isolation of a Seoul virus implicated in human disease, United Kingdom, October 2012. Euro Surveill (2013) 1.20
Binding specificities of wild-type and cloned Escherichia coli strains that recognize globo-A. Infect Immun (1989) 1.20
Respiratory health effects from exposure to carbon black: results of the phase 2 and 3 cross sectional studies in the European carbon black manufacturing industry. Occup Environ Med (2001) 1.20
Musical hallucinations. The sounds of silence? J Am Geriatr Soc (1989) 1.19
Effects of recombinant human colony stimulating factors (CSF) (granulocyte-macrophage CSF, granulocyte CSF, and CSF-1) on human monocyte/macrophage differentiation. J Immunol (1989) 1.18
Serological cross-reactions between the hemagglutinin subunits of H0N1 and H1N1 influenza viruses detected with "monospecific" antisera. J Virol (1973) 1.18
Reliability and validity of the Short Portable Mental Status Questionnaire administered by telephone. J Geriatr Psychiatry Neurol (1994) 1.13
Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin Immunol Immunopathol (1992) 1.12
An analysis of waiting times in a pediatric emergency department. Clin Pediatr (Phila) (1985) 1.08
Cutaneous manifestations in inflammatory bowel disease. Z Gastroenterol (2001) 1.08
Council tax valuation band as marker of deprivation and of general practice workload. Public Health (2000) 1.07
Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria. Free Radic Biol Med (2001) 1.06
1H, 13C, and 31P nuclear magnetic resonance studies of cowpea mosaic virus: detection and exchange of polyamines and dynamics of the RNA. Virology (1985) 1.05
Quantitative aspects of free fatty acid metabolism in the fasted rat. J Lipid Res (1967) 1.05
Donepezil improves symptoms of delirium in dementia: implications for future research. J Geriatr Psychiatry Neurol (1998) 1.04
Cerebrospinal-fluid test for new-variant Creutzfeldt-Jakob disease. Lancet (1996) 1.04
Dietary control of lipogenesis in vivo in host tissues and tumors of mice bearing Ehrlich ascites carcinoma. Cancer Res (1980) 1.03
Hepatic triglyceride secretion in relation to lipogenesis and free fatty acid mobilization in fasted and glucose-refed rats. J Lipid Res (1968) 1.03
Globo-A--a new receptor specificity for attaching Escherichia coli. FEBS Lett (1988) 1.02
Effect of glucose ingestion on the metabolism of free fatty acids in human subjects. J Lipid Res (1969) 1.01
Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings. Schizophr Res (1994) 1.01
Amino acid composition of polypeptides from influenza virus particles. J Gen Virol (1972) 1.01
Pleural effusion and a pelvic mass. Postgrad Med J (1998) 1.00
Phase I study of recombinant human tumor necrosis factor alpha in advanced malignant disease. Cancer Immunol Immunother (1989) 0.99
Atypical fibroxanthoma of the skin with metastasis. Cancer (1986) 0.98
Prescriptive authority for nurse practitioners. Geriatr Nurs (1982) 0.98
Sensory physiology and catecholamines in schizophrenia and mania. Psychiatry Res (1990) 0.98
The effect of high intakes of casein and casein phosphopeptide on calcium absorption in the rat. Br J Nutr (2000) 0.97
The osteodystrophy of mucolipidosis type III and the effects of intravenous pamidronate treatment. J Inherit Metab Dis (2002) 0.97
Characteristics of the cholesterol-esterifying activity in normal and atherosclerotic rabbit aortas. Circ Res (1974) 0.97
3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis. Brain Res Mol Brain Res (2001) 0.97
Trypsin suppression of pancreatic enzyme secretion. Differential effect on cholecystokinin release and the enteropancreatic reflex. Gastroenterology (1986) 0.96
Good and bad patients: a review of the literature and a theoretical critique. J Adv Nurs (1982) 0.96
Feasibility study of a real-time PCR test for meticillin-resistant Staphylococcus aureus in a point of care setting. J Hosp Infect (2009) 0.96
Penetrating injury of the spinal cord. Injury (1984) 0.94
Infection control hazards of intraoperative forced air warming. J Hosp Infect (2002) 0.94
Flux of free fatty acids among host tissues, ascites fluid, and Ehrlich ascites carcinoma cells. J Lipid Res (1974) 0.93
Systemic fluoride poisoning resulting from a fluoride skin burn. J Occup Med (1973) 0.93
Gambling as a social activity of older adults. Int J Aging Hum Dev (2001) 0.93
Mormon demographic history I. Nuptiality and fertility of once-married couples. Popul Stud (Camb) (1978) 0.91
Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy? Clin Exp Allergy (1998) 0.91
Anthrax meningitis in Zimbabwe. Cent Afr J Med (1981) 0.91
How research can help control tuberculosis. Int J Tuberc Lung Dis (2009) 0.91
LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma. Cancer (1997) 0.89
Opioid receptor density changes in Alzheimer amygdala and putamen. Brain Res (1993) 0.89
Auditory sensory gating and catecholamine metabolism in schizophrenic and normal subjects. Psychiatry Res (1992) 0.89
Late life gambling: the attitudes and behaviors of older adults. J Gambl Stud (2000) 0.88
Possible involvement of alpha-2A adrenergic receptors in attention deficit hyperactivity disorder: radioligand binding and polymorphism studies. Am J Med Genet B Neuropsychiatr Genet (2006) 0.88
Neurophysiological assessment of sensory gating in psychiatric inpatients: comparison between schizophrenia and other diagnoses. Biol Psychiatry (1987) 0.88
Effect of glucose feeding on net transport of plasma free fatty acids. J Lipid Res (1969) 0.88
The role of the insulin-like growth factor system in the developing brain. Horm Res (1998) 0.88
Noise and the classical musician. BMJ (1993) 0.88
Measurement of glucose recycling and liver glycogen synthesis in mice using doubly labeled substrates. Fed Proc (1977) 0.88
Slc11a1 (formerly NRAMP1) gene modulates both acute inflammatory reactions and pristane-induced arthritis in mice. Genes Immun (2006) 0.88
A community/hospital leg ulcer service. J Wound Care (1997) 0.88
Lack of relationship of auditory gating defects to negative symptoms in schizophrenia. Schizophr Res (1991) 0.87
PGP9.5: a marker for cellular neurothekeoma. Am J Surg Pathol (1999) 0.87
The nature of psychotic symptoms in senile dementia of the Alzheimer type. J Geriatr Psychiatry Neurol (1988) 0.87
Disease self-management needs of adolescents with cancer: perspectives of adolescents with cancer and their parents and healthcare providers. J Cancer Surviv (2012) 0.87
Performance specification for lower limb orthotic devices. Clin Biomech (Bristol, Avon) (2004) 0.86
Lung function in acromegaly. Q J Med (1978) 0.86
Lipogenic activation after nibbling and gorging in mice. J Lipid Res (1973) 0.86
The experiences of cancer patients. QJM (2011) 0.86